Melanoma and Cutaneous Malignancies

The following activities are available for articles related to melanoma skin cancer.

• Tremelimumab (CP-675,206), a Cytotoxic T Lymphocyte–Associated Antigen 4 Blocking Monoclonal Antibody in Clinical Development for Patients with Cancer
• Review: Anti–CTLA-4 Antibody Ipilimumab: Case Studies of Clinical Response and Immune-Related Adverse Events
• Helping Melanoma Patients Decide Whether or Not to Choose Adjuvant High-Dose Interferon-α2b EXPIRED
• Melanoma EXPIRED
• Recent Advances in Melanoma Biology EXPIRED
• The Melanoma Epidemic: Res Ipsa Loquitur EXPIRED
• Pros and Cons of Adjuvant Interferon in the Treatment of Melanoma EXPIRED